{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:04:15Z","timestamp":1784541855518,"version":"3.55.0"},"reference-count":67,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15722","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:28:09Z","timestamp":1782278889000},"page":"1-15","source":"Crossref","is-referenced-by-count":0,"title":["Identification of neoadjuvant chemoradiotherapy resistance\u2011associated proteins in locally advanced rectal cancer: A pilot study"],"prefix":"10.3892","volume":"32","author":[{"given":"Jiang-Yi","family":"He","sequence":"first","affiliation":[{"name":"Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Hao","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Wei","family":"Ran","sequence":"additional","affiliation":[{"name":"Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao-Rui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Han","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen-Lin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Jun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"key20260720122144_b1-ol-32-2-15722","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"key20260720122144_b2-ol-32-2-15722","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J Natl Cancer Cent"},{"key":"key20260720122144_b3-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S1470-2045(15)00120-5","article-title":"High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: A prospective observational study","volume":"16","author":"Appelt","year":"2015","journal-title":"Lancet Oncol"},{"key":"key20260720122144_b4-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1200\/JCO.24.01160","article-title":"Management of locally advanced rectal cancer: ASCO guideline","volume":"42","author":"Scott","year":"2024","journal-title":"J Clin Oncol"},{"key":"key20260720122144_b5-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1470-2045(20)30557-X","article-title":"Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: A retrospective, international, multicentre registry study","volume":"22","author":"Fernandez","year":"2021","journal-title":"Lancet Oncol"},{"key":"key20260720122144_b6-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1200\/JCO.21.01667","article-title":"Multicenter, randomized, phase III Trial of Short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR)","volume":"40","author":"Jin","year":"2022","journal-title":"J Clin Oncol"},{"key":"key20260720122144_b7-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.1200\/JCO.20.01932","article-title":"Multicenter, randomized, Phase III trial of neoadjuvant chemoradiation with capecitabine and irinotecan guided by UGT1A1 status in patients with locally advanced rectal cancer","volume":"38","author":"Zhu","year":"2020","journal-title":"J Clin Oncol"},{"key":"key20260720122144_b8-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.1177\/00031348221109476","article-title":"Not all patients with locally advanced rectal cancer benefit from neoadjuvant therapy","volume":"89","author":"Chang","year":"2023","journal-title":"Am Surg"},{"key":"key20260720122144_b9-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.ijrobp.2020.06.013","article-title":"Efficacy of Dose-escalated chemoradiation on complete tumor response in patients with locally advanced rectal cancer (RECTAL-BOOST): A Phase 2 randomized controlled trial","volume":"108","author":"Couwenberg","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20260720122144_b10-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s00384-021-03911-z","article-title":"KRAS mutation is predictive for poor prognosis in rectal cancer patients with neoadjuvant chemoradiotherapy: A systemic review and meta-analysis","volume":"36","author":"Peng","year":"2021","journal-title":"Int J Colorectal Dis"},{"key":"key20260720122144_b11-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"5561","DOI":"10.1158\/1078-0432.CCR-19-0908","article-title":"Integrative molecular characterization of resistance to neoadjuvant chemoradiation in rectal cancer","volume":"25","author":"Kamran","year":"2019","journal-title":"Clin Cancer Res"},{"key":"key20260720122144_b12-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1093\/annonc\/mdx401","article-title":"BRAF mutant colorectal cancer: Prognosis, treatment, and new perspectives","volume":"28","author":"Sanz-Garcia","year":"2017","journal-title":"Ann Oncol"},{"key":"key20260720122144_b13-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S1470-2045(16)30648-9","article-title":"A genome-based model for adjusting radiotherapy dose (GARD): A retrospective, cohort-based study","volume":"18","author":"Scott","year":"2017","journal-title":"Lancet Oncol"},{"key":"key20260720122144_b14-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"21572","DOI":"10.1038\/s41598-024-72818-w","article-title":"Validation of a genome-based model for adjusting radiotherapy dose (GARD) in patients with locally advanced rectal cancer","volume":"14","author":"Xia","year":"2024","journal-title":"Sci Rep"},{"key":"key20260720122144_b15-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1038\/s41591-022-01930-z","article-title":"Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer","volume":"28","author":"Chatila","year":"2022","journal-title":"Nat Med"},{"key":"key20260720122144_b16-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1002\/jcp.24894","article-title":"Clinical predictive circulating peptides in rectal cancer patients treated with neoadjuvant chemoradiotherapy","volume":"230","author":"Crotti","year":"2015","journal-title":"J Cell Physiol"},{"key":"key20260720122144_b17-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1186\/s12885-022-09960-z","article-title":"Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy","volume":"22","author":"Wang","year":"2022","journal-title":"BMC Cancer"},{"key":"key20260720122144_b18-ol-32-2-15722","first-page":"268","article-title":"Multiplexed protein signal pathway mapping identifies patients with rectal cancer that responds to neoadjuvant treatment","volume":"11","author":"Mammano","year":"2012","journal-title":"Clin Colorectal Cancer"},{"key":"key20260720122144_b19-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"28328","DOI":"10.18632\/oncotarget.16053","article-title":"Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy","volume":"8","author":"Repetto","year":"2017","journal-title":"Oncotarget"},{"key":"key20260720122144_b20-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12014-018-9192-2","article-title":"The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: A predictive proteomic signature","volume":"15","author":"Chauvin","year":"2018","journal-title":"Clin Proteomics"},{"key":"key20260720122144_b21-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/ijms17020209","article-title":"Identification of predictive markers for response to neoadjuvant chemoradiation in rectal carcinomas by proteomic isotope coded protein label (ICPL) analysis","volume":"17","author":"Croner","year":"2016","journal-title":"Int J Mol Sci"},{"key":"key20260720122144_b22-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"15412","DOI":"10.3390\/ijms242015412","article-title":"Data-Independent acquisition mass spectrometry analysis of FFPE rectal cancer samples offers In-Depth proteomics characterization of the response to neoadjuvant chemoradiotherapy","volume":"24","author":"Stanojevic","year":"2023","journal-title":"Int J Mol Sci"},{"key":"key20260720122144_b23-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jprot.2018.02.030","article-title":"Proteomic profiling of rectal cancer reveals acid ceramidase is implicated in radiation response","volume":"179","author":"Bowden","year":"2018","journal-title":"J Proteomics"},{"key":"key20260720122144_b24-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"e2100116","DOI":"10.1002\/prca.202100116","article-title":"Pilot proteomic study of locally advanced rectal cancer before and after neoadjuvant chemoradiotherapy indicates high metabolic activity in non-responders' tumor tissue","volume":"17","author":"Babic","year":"2023","journal-title":"Proteomics Clin Appl"},{"key":"key20260720122144_b25-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1021\/acs.jproteome.5c00114","article-title":"Proteomic analysis of FFPE tissue samples identifies potential molecular mechanisms mediating resistance to radiotherapy in rectal cancer","volume":"24","author":"Zott","year":"2025","journal-title":"J Proteome Res"},{"key":"key20260720122144_b26-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1245\/s10434-018-6462-1","article-title":"AJCC 8th Edition: Colorectal Cancer","volume":"25","author":"Weiser","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"key20260720122144_b27-ol-32-2-15722","article-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2012"},{"key":"key20260720122144_b28-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1021\/acs.jproteome.5b00354","article-title":"Analysis of the human adult urinary metabolome variations with age, body mass index and gender by implementing a comprehensive workflow for univariate and OPLS statistical analyses","volume":"14","author":"Th\u00e9venot","year":"2015","journal-title":"J Proteome Res"},{"key":"key20260720122144_b29-ol-32-2-15722","article-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"key":"key20260720122144_b30-ol-32-2-15722","article-title":"pheatmap: Pretty Heatmaps","author":"Kolde","year":"2019","journal-title":"R package version 1.0.12"},{"key":"key20260720122144_b31-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"W350","DOI":"10.1093\/nar\/gku396","article-title":"LocTree3 prediction of localization","volume":"42","author":"Goldberg","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"key20260720122144_b32-ol-32-2-15722","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198503279.001.0001","article-title":"Post-genome Informatics","author":"Kanehisa","year":"2000"},{"key":"key20260720122144_b33-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"6240","DOI":"10.1038\/ncomms7240","article-title":"Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells","volume":"6","author":"Wang","year":"2015","journal-title":"Nat Commun"},{"key":"key20260720122144_b34-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"6747","DOI":"10.1038\/s41388-020-01480-z","article-title":"Multifaceted role of branched-chain amino acid metabolism in cancer","volume":"39","author":"Peng","year":"2020","journal-title":"Oncogene"},{"key":"key20260720122144_b35-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s13046-023-02863-2","article-title":"MYL9 expressed in cancer-associated fibroblasts regulate the immune microenvironment of colorectal cancer and promotes tumor progression in an autocrine manner","volume":"42","author":"Deng","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"key20260720122144_b36-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s43018-019-0006-x","article-title":"L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer","volume":"1","author":"Ganesh","year":"2020","journal-title":"Nat Cancer"},{"key":"key20260720122144_b37-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"110996","DOI":"10.1016\/j.biopha.2020.110996","article-title":"Inhibiting RRM2 to enhance the anticancer activity of chemotherapy","volume":"133","author":"Zhan","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"key20260720122144_b38-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s11033-025-10510-6","article-title":"Ribonucleotide-diphosphate reductase subunit M2 (RRM2) expression and colorectal cancer invasiveness: A potential prognostic biomarker","volume":"52","author":"Yazdanian","year":"2025","journal-title":"Mol Biol Rep"},{"key":"key20260720122144_b39-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"27030","DOI":"10.1074\/jbc.M402056200","article-title":"Stable suppression of the R2 subunit of ribonucleotide reductase by R2-targeted short interference RNA sensitizes p53(\u2212\/-) HCT-116 colon cancer cells to DNA-damaging agents and ribonucleotide reductase inhibitors","volume":"279","author":"Lin","year":"2004","journal-title":"J Biol Chem"},{"key":"key20260720122144_b40-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1038\/s41556-022-00985-x","article-title":"NRF2 mediates melanoma addiction to GCDH by modulating apoptotic signalling","volume":"24","author":"Verma","year":"2022","journal-title":"Nature Cell Biology"},{"key":"key20260720122144_b41-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s10555-018-9771-8","article-title":"MACC1-the first decade of a key metastasis molecule from gene discovery to clinical translation","volume":"37","author":"Radhakrishnan","year":"2018","journal-title":"Cancer Metastasis Rev"},{"key":"key20260720122144_b42-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"e3002227","DOI":"10.1371\/journal.pbio.3002227","article-title":"Cooperative activation of PDK1 and AKT by MAPK4 enhances cancer growth and resistance to therapy","volume":"21","author":"Han","year":"2023","journal-title":"PLoS Biol"},{"key":"key20260720122144_b43-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"116408","DOI":"10.1016\/j.biopha.2024.116408","article-title":"Research progress in MCM family: Focus on the tumor treatment resistance","volume":"173","author":"Tian","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"key20260720122144_b44-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cells14010012","article-title":"Minichromosome maintenance proteins: From DNA replication to the DNA damage response","volume":"14","author":"Malysa","year":"2024","journal-title":"Cells"},{"key":"key20260720122144_b45-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3390\/applbiosci2030029","article-title":"Deregulations of RNA Pol II subunits in cancer","volume":"2","author":"Muste Sadurni","year":"2023","journal-title":"Appl Biosci"},{"key":"key20260720122144_b46-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"BSR20211577","DOI":"10.1042\/BSR20211577","article-title":"Deregulation of ribosomal proteins in human cancers","volume":"41","author":"El Khoury","year":"2021","journal-title":"Biosci Rep"},{"key":"key20260720122144_b47-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"10658","DOI":"10.1038\/s41598-022-14724-7","article-title":"Expression and prognosis analysis of mitochondrial ribosomal protein family in breast cancer","volume":"12","author":"Lin","year":"2022","journal-title":"Sci Rep"},{"key":"key20260720122144_b48-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"101392","DOI":"10.1016\/j.tranon.2022.101392","article-title":"Aminoacyl-tRNA synthetases of the multi-tRNA synthetase complex and their role in tumorigenesis","volume":"19","author":"Khan","year":"2022","journal-title":"Transl Oncol"},{"key":"key20260720122144_b49-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1136\/jclinpath-2019-206175","article-title":"High methionyl-tRNA synthetase expression predicts poor prognosis in patients with breast cancer","volume":"73","author":"Jin","year":"2020","journal-title":"J Clin Pathol"},{"key":"key20260720122144_b50-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"5413","DOI":"10.3390\/cancers15225413","article-title":"Prediction of prognosis in pancreatic cancer according to Methionyl-tRNA synthetase 1 expression as determined by immunohistochemical staining","volume":"15","author":"Jang","year":"2023","journal-title":"Cancers (Basel)"},{"key":"key20260720122144_b51-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"19635","DOI":"10.1073\/pnas.1103922108","article-title":"Dual role of methionyl-tRNA synthetase in the regulation of translation and tumor suppressor activity of aminoacyl-tRNA synthetase-interacting multifunctional protein-3","volume":"108","author":"Kwon","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20260720122144_b52-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.3748\/wjg.v19.i17.2603","article-title":"CD133: A cancer stem cells marker, is used in colorectal cancers","volume":"19","author":"Ren","year":"2013","journal-title":"World J Gastroenterol"},{"key":"key20260720122144_b53-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"104125","DOI":"10.1016\/j.ebiom.2022.104125","article-title":"Single-cell sequencing reveals CD133+CD44-originating evolution and novel stemness related variants in human colorectal cancer","volume":"82","author":"Zhang","year":"2022","journal-title":"EBioMedicine"},{"key":"key20260720122144_b54-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/s41416-020-0783-0","article-title":"Targeting CD133 reverses drug-resistance via the AKT\/NF-\u03baB\/MDR1 pathway in colorectal cancer","volume":"122","author":"Yuan","year":"2020","journal-title":"Br J Cancer"},{"key":"key20260720122144_b55-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/cbin.11243","article-title":"CD133: An emerging prognostic factor and therapeutic target in colorectal cancer","volume":"44","author":"Akbari","year":"2020","journal-title":"Cell Biol Int"},{"key":"key20260720122144_b56-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.apsb.2023.12.003","article-title":"Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer","volume":"14","author":"Liao","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"key20260720122144_b57-ol-32-2-15722","first-page":"4054","article-title":"HK2 is a radiation resistant and independent negative prognostic factor for patients with locally advanced cervical squamous cell carcinoma","volume":"8","author":"Huang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"key20260720122144_b58-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.3390\/ijms25063142","article-title":"Targeting the warburg effect in cancer: Where Do We Stand?","volume":"25","author":"Barba","year":"2024","journal-title":"Int J Mol Sci"},{"key":"key20260720122144_b59-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10409238.2020.1832438","article-title":"Human de novo purine biosynthesis","volume":"56","author":"Pareek","year":"2021","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"key20260720122144_b60-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/s41467-020-15136-9","article-title":"A shift in glutamine nitrogen metabolism contributes to the malignant progression of cancer","volume":"11","author":"Kodama","year":"2020","journal-title":"Nat Commun"},{"key":"key20260720122144_b61-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"1834902","DOI":"10.1080\/23723556.2020.1834902","article-title":"Purine metabolism promotes radioresistance and is a therapeutic target in glioblastoma","volume":"7","author":"Zhou","year":"2020","journal-title":"Mol Cell Oncol"},{"key":"key20260720122144_b62-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"4844","DOI":"10.1021\/pr9004162","article-title":"Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS","volume":"8","author":"Qiu","year":"2009","journal-title":"J Proteome Res"},{"key":"key20260720122144_b63-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11306-022-01959-8","article-title":"Changes of serum metabolites levels during neoadjuvant chemoradiation and prediction of the pathological response in locally advanced rectal cancer","volume":"18","author":"Lv","year":"2022","journal-title":"Metabolomics"},{"key":"key20260720122144_b64-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ccell.2019.12.011","article-title":"Emerging roles for Branched-chain amino acid metabolism in cancer","volume":"37","author":"Sivanand","year":"2020","journal-title":"Cancer Cell"},{"key":"key20260720122144_b65-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0350-z","article-title":"Branched-chain amino acids sustain pancreatic cancer growth by regulating lipid metabolism","volume":"51","author":"Lee","year":"2019","journal-title":"Exp Mol Med"},{"key":"key20260720122144_b66-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1111\/exd.14865","article-title":"BCKDHA contributes to melanoma progression by promoting the expressions of lipogenic enzymes FASN and ACLY","volume":"32","author":"Tian","year":"2023","journal-title":"Exp Dermatol"},{"key":"key20260720122144_b67-ol-32-2-15722","doi-asserted-by":"publisher","first-page":"151154","DOI":"10.1016\/j.bbrc.2024.151154","article-title":"Dephosphorylation of branched-chain \u03b1-keto acid dehydrogenase E1\u03b1 (BCKDHA) promotes branched-chain amino acid catabolism and renders cancer cells resistant to X-rays by mitigating DNA damage","volume":"742","author":"Bo","year":"2025","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:21:53Z","timestamp":1784539313000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":67,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6,24]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15722","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]}}}